David Grainger
2022
In 2022, David Grainger earned a total compensation of $2.4M as Former Chief Innovation Officer at Centessa Pharmaceuticals plc.
Compensation breakdown
| Bonus | $172,483 |
|---|---|
| Option Awards | $1,273,882 |
| Salary | $464,069 |
| Stock Awards | $517,000 |
| Other | $20,371 |
| Total | $2,447,805 |
Grainger received $1.3M in option awards, accounting for 52% of the total pay in 2022.
Grainger also received $172.5K in bonus, $464.1K in salary, $517K in stock awards and $20.4K in other compensation.
Rankings
In 2022, David Grainger's compensation ranked 1,486th out of 5,756 executives tracked by ExecPay. In other words, Grainger earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,486 out of 5,756 | 74th |
Division Manufacturing | 746 out of 3,133 | 76th |
Major group Chemicals And Allied Products | 291 out of 1,419 | 80th |
Industry group Drugs | 270 out of 1,320 | 80th |
Industry Pharmaceutical Preparations | 193 out of 966 | 80th |
Source: SEC filing on May 9, 2024.
Grainger's colleagues
We found four more compensation records of executives who worked with David Grainger at Centessa Pharmaceuticals plc in 2022.